Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy

Clinical trial NCT00549692 · COMPLETED

Trial details

NCT number: NCT00549692
Sponsor: Kuhnil Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2007-11-01
Primary completion: 2012-08-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.